SCHEMBL1615131

SCHEMBL1615131

CC(C)CN1C(=O)S/C(=C\c2cc(O)c(O)c(C(F)(F)F)c2)C1=O

nearest known ligand 0.61

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 2/20 0.61
▸ COMT P21964 1/20 0.49
▸ AKR1B1 P15121 1/20 0.42
▸ BAG3 O95817 1/20 0.42
▸ PPARG P37231 1/20 0.41
▸ ESRRA P11474 1/20 0.41
▸ CFTR P13569 1/20 0.40
▸ EP300 Q09472 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614974 0.89 SLC2A1 (0.77) SLC2A1COMTAKR1B1BAG3PPARG
SCHEMBL1614297 0.87 SLC2A1 (0.80) SLC2A1AKR1B1BAG3PPARGESRRA
SCHEMBL1614901 0.86 SLC2A1 (0.69) SLC2A1COMTAKR1B1BAG3PPARG
SCHEMBL12712457 0.84 COMT (0.53) SLC2A1COMTAKR1B1BAG3PPARG
SCHEMBL1614304 0.83 SLC2A1 (0.52) SLC2A1COMTPPARG
SCHEMBL12737009 0.81 SLC2A1 (0.61) SLC2A1COMTAKR1B1BAG3PPARG
SCHEMBL1614533 0.81 NLRP3 (0.55) SLC2A1PPARG
SCHEMBL1614850 0.80 PRKAG1 (0.54) SLC2A1COMTAKR1B1BAG3PPARG
SCHEMBL1614943 0.80 PIM1 (0.53) SLC2A1COMTAKR1B1PPARGESRRA
SCHEMBL1614940 0.79 SLC2A1 (0.52) SLC2A1COMTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US claimed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 — — EP disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS PCK2, AK2, SIRT6 SLC2A1 76/4885COMT 4225/4885AKR1B1 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback